Exchange Announcement • 19 Nov 2025 13:39
Exchange Announcement • 19 Nov 2025 05:32
Exchange Announcement • 17 Nov 2025 09:11
Exchange Announcement • 17 Nov 2025 09:08
Exchange Announcement • 17 Nov 2025 09:07
Search or
𝛼SK
𝛼SKENTITY
Paradigm Biopharmaceuticals (PAR AU)
Paradigm Biopharmaceuticals (PAR AU)
21
Analysis
Health Care • Australia
Paradigm Biopharmaceuticals Limited operates as a biopharmaceutical company. The Company develops PPS drug to treat respiratory diseases such as allergic asthma, allergic rhinitis, and chronic obstructive pulmonary. Paradigm Biopharmaceuticals offers its services in Australia.
morex